Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Nov 2022 – 20 Aug 2026, limited by HSBC NIFTY NEXT 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | HSBC NIFTY NEXT 50 Index Fund | Nifty 50 |
|---|---|---|
| 28 Nov 2022 | ₹100.00 | ₹100.00 |
| 21 Mar 2023 | ₹87.77 | ₹92.16 |
| 13 Jul 2023 | ₹102.08 | ₹104.58 |
| 03 Nov 2023 | ₹104.19 | ₹103.60 |
| 25 Feb 2024 | ₹137.26 | ₹119.66 |
| 17 Jun 2024 | ₹166.39 | ₹126.41 |
| 09 Oct 2024 | ₹174.40 | ₹134.58 |
| 30 Jan 2025 | ₹143.65 | ₹125.25 |
| 23 May 2025 | ₹154.64 | ₹133.89 |
| 14 Sep 2025 | ₹157.65 | ₹135.29 |
| 05 Jan 2026 | ₹162.54 | ₹141.41 |
| 29 Apr 2026 | ₹162.92 | ₹130.25 |
| 20 Aug 2026 | ₹171.31 | ₹130.54 |
| Metric | HSBC · Regular NAV ₹31.69 Very High risk ★★★★☆ | Category median Index Funds · 366 funds |
|---|---|---|
| +8.73% | +5.43% | |
| +18.98% | +8.41% | |
| — | +8.95% | |
| — | +11.28% | |
| +15.54% | +7.40% | |
| +13.92% | — | |
| +18.78% | +11.37% | |
| — | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 18.45% | 13.88% | |
| 0.68 | 0.25 | |
| 0.91 | 0.35 | |
| -26.73% | -16.66% | |
| Nifty 50 | — | |
| +9.64% | +0.30% | |
| 1.30 | 1.00 | |
| 142.1% | 101.3% | |
| 97.4% | 98.8% | |
| 0.76% | 0.96% | |
| ₹153.59Cr | ₹182.17Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 71% | 35% | |
| Praveen Ayathan | — | |
| 28 Nov 2022 | — | |
| 50 | — | |
| 32.2% | — | |
| 0.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.